iShares Nasdaq Biotechnology ETF (IBB) Shares Sold by NN Investment Partners Holdings N.V.

NN Investment Partners Holdings N.V. lowered its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 4.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,364 shares of the financial services provider’s stock after selling 491 shares during the period. NN Investment Partners Holdings N.V.’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,264,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Schroder Investment Management Group bought a new stake in iShares Nasdaq Biotechnology ETF during the second quarter worth about $105,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the second quarter worth about $134,000. KHP Capital LLC increased its holdings in shares of iShares Nasdaq Biotechnology ETF by 61.1% in the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock worth $159,000 after buying an additional 550 shares during the period. Private Wealth Advisors Inc. purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the second quarter worth about $201,000. Finally, Valmark Advisers Inc. purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the second quarter worth about $202,000. 63.62% of the stock is owned by hedge funds and other institutional investors.

IBB opened at $108.50 on Wednesday. iShares Nasdaq Biotechnology ETF has a 12 month low of $100.22 and a 12 month high of $122.97.

WARNING: “iShares Nasdaq Biotechnology ETF (IBB) Shares Sold by NN Investment Partners Holdings N.V.” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/11/07/ishares-nasdaq-biotechnology-etf-ibb-shares-sold-by-nn-investment-partners-holdings-n-v.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: Fundamental Analysis – How It Helps Investors

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply